Ebru Ercan-Herbst

My research primarily focuses on investigating neuron-oligodendrocyte interactions and identifying the molecular mechanisms underlying myelination deficits. During my postdoctoral studies at Harvard Medical School, my work centered around autism spectrum disorders, where I discovered a neuronal factor that hinders oligodendrocyte development, leading to deficits in myelination. Over the past four years, I have been leading a team of scientists at the BioMed X Institute in Heidelberg. My research revolves around exploring early intervention strategies for schizophrenia, with a specific emphasis on the hypomyelination pathology. In pursuit of these goals, my team develops physiologically-relevant in vivo and in vitro platforms. We also employ transcriptomics analysis on post-mortem brain samples to identify potential factors contributing to hypomyelination pathology of schizophrenia.